Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > New week, day, month, post, threads

<< Previous

Bullboard Posts

Next >>

Comment by lonc17on Mar 31, 2024 6:37pm

106 Views

Post# 35961940

RE:RE:New week, day, month, post, threads

I found the issue that caused incomplete results from SEDI.

This is at the top of the page of the search I perform (I did not see notice it earlier when I first made the post):

March 31, 2024

Insider transaction detail - View details for issuer

Transactions sorted by : Insider
Issuer name : oncolytics biotech ( Starts with )

Error: Your search returned more results than can be displayed. The results displayed on the screen may be misleading as they do not necessarily constitute a complete and accurate representation of the correct information. To get complete results, you need to refine your search criteria to narrow your search.

<< Previous

Bullboard Posts

Next >>

Odd Burger to add 40 locations in Florida